Abstract
Get full access to this article
View all access options for this article.
References
1.All Info—H.R.8454—117th Congress (2021–2022): Medical Marijuana and Cannabidiol Research Expansion Act . (2022 , December 2 ). https://www.congress.gov/bill/117th-congress/house-bill/8454/all-info
2.National Conference of State Legislators (NCSL) . (2022 ).
State medical marijuana laws
. http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
3.U.S. Food and Drug Administration . (2019 ).
FDA, FTC warn company marketing unapproved cannabidiol products with unsubstantiated claims to treat teething and ear pain in infants, autism, ADHD, Parkinson’s and Alzheimer’s disease
. https://www.fda.gov/news-events/press-announcements/fda-ftc-warn-company-marketing-unapproved-cannabidiol-products-unsubstantiated-claims-treat-teething